We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Tbl3.0
Turinabol (4-Chlorodehydromethyltestosterone) Research
Mostly mechanism / observationalLimited safety
6 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Turinabol (4-Chlorodehydromethyltestosterone) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality studies published 1997–2026 with a typical study size of 5 participants.
Based on 6 studies · 5 total participants
Confidence
Low
By outcome
Lean mass & anabolic effect
Mostly mechanism / observational6 studies
Hormones & virilization
Mostly mechanism / observational5 studies
Safety profile
Mostly mechanism / observational3 studies
Liver & hepatotoxicity
Too few graded studies1 study
Cardiovascular harm
Too few graded studies1 study
Active research area
2 studies in the last 5 years
199720112026
1Observational1997
Several thousand athletes were treated with androgens every year, including minors of each sex. Special emphasis was placed on administering androgens to women and adolescent girls because this practice proved to be particularly effective for sports success.
Franke WW, Berendonk B · Clinical chemistry (1997)
Field-defining historical documentation, reconstructed from classified Stasi files after the GDR's 1990 collapse — the central drug of the program was Oral Turinabol (4-chlorodehydromethyltestosterone)
From 1966 onward, hundreds of physicians and scientists administered androgens to several thousand athletes a year, including minors of both sexes, frequently without their knowledge or consent
Documents severe androgenization and virilization, especially in women and adolescent girls, alongside hepatic and other health damage
2Review2026
A conspiratorial, state-controlled program of compulsory doping ... affected an estimated 15,000 underage athletes ... administered covertly, without the knowledge, information, or consent of those affected, often before puberty and despite known health risks.
Spitzer C, Bley B · Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz (2026)
Contemporary review of the long-term health consequences of the GDR's compulsory doping program — anabolic-androgenic steroids (Oral Turinabol foremost) as its core
Estimates ~15,000 underage athletes were dosed covertly, often before puberty and without consent
Catalogues lasting biopsychosocial damage — disrupted hormonal regulation, organ damage and psychiatric harm — still evident in survivors decades later
3Observationaln=5 · very small study2021
Dehydrochloromethyltestosterone (DHCMT) is an anabolic-androgenic steroid that was developed by Jenapharm in the 1960s and was marketed as Oral Turinabol. It is prohibited in sports at all times.
Loke S, de la Torre X, Iannone M, La Piana G, Schlörer N, Botrè F · The Journal of steroid biochemistry and molecular biology (2021)
Controlled administration of a single 5 mg oral dose of DHCMT to five healthy male volunteers, with urine collected for 60 days
Characterizes urinary excretion and confirms long-term metabolites enabling retrospective anti-doping detection (the basis of 2008/2012 Olympic retest findings)
Pharmacology/detection anchor — the only modern controlled human dosing exists for anti-doping science, not efficacy
In sport, these agents are performance enhancers, this being particularly apparent in women, although there is a high risk of virilization despite the favourable myotrophic-androgenic dissociation that many xenobiotic steroids confer.
Kicman AT · British journal of pharmacology (2008)
Authoritative review of anabolic-androgenic steroid pharmacology — the mechanistic frame for turinabol as a 17α-alkylated, orally active AAS
Performance enhancement is most apparent in women, but with a high risk of virilization — directly explaining the GDR program's emphasis on, and harm to, female and underage athletes
Covers androgen-receptor mechanism, oral 17α-alkylation, and the hepatotoxic and endocrine trade-offs of the class
In our own cases, severe cardiovascular side-effects developed after long-term abuse of Dianabol (methandrostenolone) and Oral-Turinabol (chlordehydromethyltestosterone), i.e. myocardial infarction, stroke, organomegaly and/or severe atherosclerosis.
Madea B, Grellner W, Musshoff F, Dettmeyer R · Journal of clinical forensic medicine (1998)
Forensic case material plus literature review of fatalities and long-term effects of anabolic-steroid abuse, naming Oral Turinabol explicitly
Severe cardiovascular outcomes after long-term abuse — myocardial infarction, stroke, organomegaly and severe atherosclerosis
Notes black-market AAS products did not contain the expected ingredients in 35% of cases (counterfeit/adulteration risk)
A 32-year-old man underwent right radical orchiectomy for a tumor ... The patient reported a 5-year history of systematic use of high dose Oral-Turinabol (4-chloro-1-dehydro-17alpha-methyltestosterone).
Froehner M, Fischer R, Leike S, Hakenberg OW, Noack B, Wirth MP · Cancer (1999)
Case report of an intratesticular leiomyosarcoma in a 32-year-old man after a five-year history of high-dose Oral Turinabol
First reported possible association between androgenic anabolic steroids and leiomyosarcoma in humans
Adds a documented neoplastic outcome to the harm record of high-dose turinabol use